Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis C - Genotype 3”

155 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 155 results

Testing effectiveness (Phase 2)Ended earlyNCT01425970
What this trial is testing

Chronically-infected HCV Genotype 2 and 3 Treatment-naive Subjects: Part A: Safety and Efficacy of INX-08189 With Peg IFN Alfa-2a and Ribavirin. Part B: INX-08189 in Interferon Free Treatment With Daclatasvir and/or Ribavirin

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 210
Post-approval studies (Phase 4)Study completedNCT00553930
What this trial is testing

Low Dose Peginterferon-α 2a for Chronic Hepatitis C, Genotypes 2 or 3, in HIV-coinfected Patients

Who this might be right for
Hepatitis C, ChronicHIV Infections
Sociedad Andaluza de Enfermedades Infecciosas 71
Large-scale testing (Phase 3)Study completedNCT03090035
What this trial is testing

Impact of Interleukin 28B (rs12979860) Genotype on Virological Responses Chronic Hepatitis C Treatment

Who this might be right for
Hepatitis CHepatitis C Relapse
Sheikh Zayed Medical College 98
Not applicableEnded earlyNCT01100749
What this trial is testing

Chronic Hepatitis C (CHC) - Genotype 3 Infection in Canada

Who this might be right for
Chronic Hepatitis C - Genotype 3
University Health Network, Toronto 25
Testing effectiveness (Phase 2)Study completedNCT01458535
What this trial is testing

Evaluate Paritaprevir With Ritonavir (ABT-450/r) When Given Together With Ombitasvir and With and Without Ribavirin (RBV) in Treatment-Naïve Participants With Genotype 1, 2 or 3 Chronic Hepatitis C Virus (HCV)

Who this might be right for
Hepatitis C Virus
AbbVie (prior sponsor, Abbott) 61
Post-approval studies (Phase 4)Study completedNCT00143000
What this trial is testing

Multicenter Study Evaluating 12 Versus 24 Weeks Therapy With Peginterferon and Ribavirin for Hepatitis C Virus (HCV) Genotype 2 or 3

Who this might be right for
Hepatitis C Virus
NORDynamIC Study Group 392
Large-scale testing (Phase 3)Study completedNCT01544920
What this trial is testing

Safety and Efficacy of Boceprevir/Peginterferon Alfa-2a/Ribavirin in Interleukin-28B CC Allele-Positive Chronic Hepatitis C Virus (HCV) Genotype 1 Participants (P07755)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 737
Large-scale testing (Phase 3)Study completedNCT02021643
What this trial is testing

Efficacy and Safety of Sofosbuvir Plus Ribavirin in Adults With Chronic HCV Infection

Who this might be right for
Chronic HCV Infection
Gilead Sciences 687
Large-scale testing (Phase 3)Study completedNCT02496078
What this trial is testing

Evaluation of Daclatasvir and Asunaprevir in Treatment-naive Subjects With Chronic Hepatitis C Genotype 1b Infection

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 207
Testing effectiveness (Phase 2)Study completedNCT02175758
What this trial is testing

Safety and Efficacy of Sofosbuvir + Ribavirin in Adolescents and Children With Genotype 2 or 3 Chronic HCV Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 106
Large-scale testing (Phase 3)Study completedNCT02738138
What this trial is testing

Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)

Who this might be right for
Hepatitis C Virus InfectionHuman Immunodeficiency Virus InfectionChronic Hepatitis C+1 more
AbbVie 153
Large-scale testing (Phase 3)Study completedNCT01616524
What this trial is testing

Safety and Efficacy Study of Pegylated Interferon Lambda With and Without Daclatasvir, Compared to Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C Genotype 2 and 3

Who this might be right for
Hepatitis C Virus (HCV)
Bristol-Myers Squibb 880
Large-scale testing (Phase 3)Study completedNCT01768286
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Treatment-Experienced Subjects With Genotype 1 HCV Infection

Who this might be right for
Chronic Hepatitis C Virus
Gilead Sciences 441
Testing effectiveness (Phase 2)Study completedNCT01260350
What this trial is testing

Open-Labeled Study of PSI-7977 and RBV With and Without PEG-IFN in Treatment-Naïve Patients With HCV GT2 or GT3

Who this might be right for
Chronic Hepatitis C Infection
Gilead Sciences 292
Testing effectiveness (Phase 2)Study completedNCT00561015
What this trial is testing

A Phase 2a Study to Evaluate Viral Kinetics and Safety of Telaprevir in Participants With Genotype 2 or 3 Hepatitis C Infection

Who this might be right for
Hepatitis C, Chronic
Tibotec BVBA 52
Early research (Phase 1)Study completedNCT02116543
What this trial is testing

TD-6450 MAD Study in HCV Infected Subjects

Who this might be right for
Hepatitis CHCV
Theravance Biopharma 47
Large-scale testing (Phase 3)Study completedNCT01753557
What this trial is testing

Efficacy and Safety of MP-424, Peginterferon Alfa-2a (PEG-IFN Alfa-2a), and Ribavirin(RBV) in Treatment-Naïve or Relapsed Hepatitis C

Who this might be right for
Chronic Hepatitis C (CHC)
Tanabe Pharma Corporation 54
Large-scale testing (Phase 3)Study completedNCT01468584
What this trial is testing

Efficacy and Safety of MP-424, Peginterferon Alfa-2b and Ribavirin in Non-responder Genotype 2 Hepatitis C Infected Patients

Who this might be right for
Chronic Hepatitis C
Tanabe Pharma Corporation 10
Large-scale testing (Phase 3)Study completedNCT00780416
What this trial is testing

Efficacy and Safety of MP-424/Peginterferon Alfa-2b/Ribavirin Combination in Treatment-Naïve Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C
Tanabe Pharma Corporation 189
Large-scale testing (Phase 3)Study completedNCT01667731
What this trial is testing

Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Adults

Who this might be right for
Hepatitis CHuman Immunodeficiency Virus
Gilead Sciences 224
Load More Results